aA
Application of low-intensity pulsed ultrasound in combination with microbubbles might enhance the delivery of chemotherapy medication used for treating cancers. In their study, a team of Lithuanian researchers from three universities – KTU, LSMU and VMU – claim that the rate of microbubble survival time is the best indicator for determining the efficiency of sonoporation, i.e. ultrasound-induced laceration of the cancer cell membrane.
Krūties vėžys
Krūties vėžys
© Shutterstock

Poor drug delivery into cancer cells is one of the greatest concerns in anticancer therapy. Insufficient drug concentration in the tumour limits medication’s therapeutic efficacy, therefore the researchers all over the world are looking for solutions that would enhance its transport into cancer cells. One of the methods that are getting increased attention recently is sonoporation caused by ultrasound.

There are two main mechanisms by which ultrasound may affect drug transport into cells. Firstly, under the effect of ultrasound, all fluid starts moving in oscillatory fashion and this may enhance the diffusion of the molecules through the cell membrane. Another mechanism includes usage of microbubbles to damage the structure of cells. The tiny (1–4 μm in diameter) gas-filled spheres coated with a shell made of lipids, polymers, and proteins are used to enhance the ultrasound imaging procedure. It has been observed that ultrasound causes microbubbles to rapidly expand and contract – this phenomenon is called cavitation. Cavitation causes the flow of the fluid around the microbubble, and the produced shear forces may create small pores in cell membranes.

“The method where ultrasound together with microbubbles is used to improve the anticancer medication delivery into cancer cells is widely researched. Although mainly research is conducted in a laboratory environment during in vitro studies, first clinical trials have already started. We believe that our research results will add to the development of global knowledge in this critical topic”, says professor Dr Renaldas Raišutis, Head of Numerical Simulation Laboratory of Ultrasound Research Institute at Kaunas University of Technology (KTU).

Renaldas Raišutis
Renaldas Raišutis
© KTU archyvas

While researching the sonoporation for improving the efficiency of the anticancer medication, the multi-disciplinary team of researchers from three Lithuanian universities worked together – Lithuanian University of Health Sciences (LSMU), Vytautas Magnus University (VMU) and KTU. After numerous studies, in which the researchers analysed ultrasound penetration signals under different acoustic pressure and duration of exposure, they have improved the method of predicting the efficiency of sonoporation. The research conducted by Lithuanian scientists reveals that microbubble survival time is the universal estimate, which defines the optimal duration of exposure for sonoporation.

“Our main finding is that only time-dependent estimate, the rate of microbubble survival time is needed to predict the efficiency of sonoporation. Therefore, our metrics are more advanced than the currently used inertia cavitation control variable”, explains Prof Raišutis.

Moreover, while studying the anticancer medication doxorubicin delivery into spherical (3D) cancer cell culture (a model for conducting experiments, which is more closely able to mimic conditions in vivo), KTU researchers together with the team from LSMU have determined the ultimate combination of microbubbles and ultrasound, that would enhance the transport of the drug into the tumour tissue.
During the research, which took place over several years, the scientists from KTU, LSMU and VMU were solving numerous problems related to the development of the ultrasound technology needed for delivering anticancer medication, the determination of ultrasound parameters for exposure and analysing the ultrasound penetration signals. According to Prof Raišutis, all the partners have actively participated and contributed to the research according to their fields of expertise.

DELFI EN
It is forbidden to copy the text of this publication without a written permission from DELFI.

Man dies after COVID-19 shot death not linked to vaccine

A 77-year-old man has died in Lithuania after receiving a COVID-19 vaccine shot but his death is not...

Lithuania ranks 15th in Europe by COVID-19 case 9th in by death rates

Lithuania comes in 15th in terms of the 14-day COVID-19 case notification rate among the European...

Lithuanian-Polish relations targeted in information attack

An information attack was carried out against Lithuanian-Polish relations and NATO on Friday, the...

President: vaccine schedule allows vaccinating 70 pct by mid-summer

A new COVID-19 vaccine delivery schedule creates possibilities for vaccinating 70 percent of...

624 new coronavirus cases

On Thursday, 624 new COVID-19 cases were recorded in Lithuania. In total, the country has already...

Top news

Man dies after COVID-19 shot death not linked to vaccine

A 77-year-old man has died in Lithuania after receiving a COVID-19 vaccine shot but his death is not...

OECD: Lithuania needs to boost municipal borrowing capacity

Lithuania needs to increase the borrowing capacity of its municipalities for public investment to...

5 smart city solutions from KTU students for Kaunas

Smart waste collection systems, advanced street lighting, mobile applications informing on the traffic...

Lithuania ranks 15th in Europe by COVID-19 case 9th in by death rates

Lithuania comes in 15th in terms of the 14-day COVID-19 case notification rate among the European...

President: vaccine schedule allows vaccinating 70 pct by mid-summer

A new COVID-19 vaccine delivery schedule creates possibilities for vaccinating 70 percent of...